Stockreport

Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes

DarioHealth Corp.  (DRIO) 
NASDAQ:AMEX Investor Relations: dariohealth.com/our-story
PDF Quasi-randomized study demonstrates the value of Dario's integrated approach to provide one solution for members to manage diabetes, pre-diabetes, blood pressure, weight [Read more]